ArticleMedicina (Kaunas, Lithuania)2026
Intensive Versus Non-Intensive Therapy in Older Patients with Acute Myeloid Leukemia: A Real-World Experience.
Dila Elifsu Yuksekli, Arda Bayar, Ceren Uzunoglu Guren, Fatma Arikan, Fatma Temiz, Ahmet Mert Yanik, Tayfur Toptas, Isik Kaygusuz Atagunduz, Tulin Tuglular, Asu Fergun Yilmaz
Abstract read
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Dila Elifsu YuksekliDepartment of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey.ORCID 0000-0001-8788-8222 Arda BayarDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.ORCID 0000-0002-4586-3809 Ceren Uzunoglu GurenDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.ORCID 0000-0001-5544-1880 Fatma ArikanDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.
Fatma TemizDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.ORCID 0000-0001-8102-8627 Ahmet Mert YanikDepartment of Hematology, University of Health Sciences, Bursa City Training and Research Hospital, 16110 Bursa, Turkey.ORCID 0000-0002-1908-0149 Tayfur ToptasDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.ORCID 0000-0002-2690-8581 Isik Kaygusuz AtagunduzDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.ORCID 0000-0002-7876-6896 Tulin TuglularDepartment of Hematology, Acibadem Hospital, 34718 Istanbul, Turkey.
Asu Fergun YilmazDepartment of Hematology, Marmara University Pendik Training and Research Hospital, 34854 Istanbul, Turkey.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myeloid, AcuteAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansKaplan-Meier EstimateMaleRetrospective StudiesTreatment Outcome65 years and olderacute myeloid leukemiaintensive therapynon-intensive therapyoverall survival
Identifiers
PMID42796339
PMCPMC13609752
What OpenQuestion holds
Textmetadata
Read underepoch 390